Literature DB >> 26483063

Anemia and Functional Disability in Older Adults With Cancer.

Cynthia Owusu1, Harvey Jay Cohen1, Tao Feng1, William Tew1, Supriya G Mohile1, Heidi D Klepin1, Cary P Gross1, Ajeet Gajra1, Stuart M Lichtman1, Arti Hurria1.   

Abstract

OBJECTIVES: Anemia is associated with functional disability among older adults in general. However, the relationship between anemia and functional disability has not been well characterized among older adults with cancer. Therefore, we examined the association between anemia and functional disability in patients with cancer aged 65 years or older. PATIENTS AND METHODS: We conducted cross-sectional analysis of data derived from a multicenter prospective study of 500 patients with cancer aged 65 years or older. The primary outcome was functional disability at chemotherapy initiation, defined as the need for assistance with at least one instrumental activity of daily living. Anemia (using WHO criteria) was defined as a hemoglobin (Hb) level of less than 12 g/dL in women and less than 13 g/dL in men. Multivariable logistic regression was used to examine the association between anemia and functional disability.
RESULTS: Among 491 evaluable patients (median age, 73.1 years [range, 65-91 years]), the prevalence of functional disability and anemia was 43% and 51%, respectively. Compared with patients without anemia, patients with anemia were more likely to report functional disability. On multivariable analysis, adjusting for sex, stage, and unintentional weight loss, patients with anemia were more likely to have functional disability (odds ratio, 2.40; 95% CI, 1.61-3.59).
CONCLUSIONS: Anemia was highly prevalent and independently associated with functional disability in this cohort of older adults with cancer. Given the importance of functional status in cancer treatment decision-making, longitudinal studies evaluating the causal relation between anemia and functional status among older patients with cancer are warranted to evaluate causality.
Copyright © 2015 by the National Comprehensive Cancer Network.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26483063      PMCID: PMC4832423          DOI: 10.6004/jnccn.2015.0152

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  38 in total

1.  The MOS social support survey.

Authors:  C D Sherbourne; A L Stewart
Journal:  Soc Sci Med       Date:  1991       Impact factor: 4.634

2.  Serum hemoglobin level determined at the first presentation is a poor prognostic indicator in patients with lung cancer.

Authors:  Keisuke Aoe; Akio Hiraki; Tadashi Maeda; Hideki Katayama; Keiichi Fujiwara; Masahiro Tabata; Katsuyuki Kiura; Hiroshi Ueoka; Mitsune Tanimoto
Journal:  Intern Med       Date:  2005-08       Impact factor: 1.271

3.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

4.  Management of cancer-related anemia in patients with breast or gynecologic cancer: new insights based on results from the European Cancer Anemia Survey.

Authors:  Peter Barrett-Lee; Carsten Bokemeyer; Pere Gascón; J W R Nortier; Maurice Schneider; Dirk Schrijvers; Simon Van Belle
Journal:  Oncologist       Date:  2005-10

5.  Prognostic value of anemia in newly diagnosed metastatic prostate cancer: a multivariate analysis of southwest oncology group study 8894.

Authors:  Tomasz M Beer; Catherine M Tangen; Lisa B Bland; Ian M Thompson; E David Crawford
Journal:  J Urol       Date:  2004-12       Impact factor: 7.450

Review 6.  Chemotherapy-induced anemia in adults: incidence and treatment.

Authors:  J E Groopman; L M Itri
Journal:  J Natl Cancer Inst       Date:  1999-10-06       Impact factor: 13.506

7.  Erythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trial.

Authors:  Michael Henke; Roland Laszig; Christian Rübe; Ulrich Schäfer; Klaus-Dieter Haase; Burkhard Schilcher; Stephan Mose; Karl T Beer; Ulrich Burger; Chris Dougherty; Hermann Frommhold
Journal:  Lancet       Date:  2003-10-18       Impact factor: 79.321

8.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

9.  Validation of a short Orientation-Memory-Concentration Test of cognitive impairment.

Authors:  R Katzman; T Brown; P Fuld; A Peck; R Schechter; H Schimmel
Journal:  Am J Psychiatry       Date:  1983-06       Impact factor: 18.112

10.  Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group.

Authors:  C L Loprinzi; J A Laurie; H S Wieand; J E Krook; P J Novotny; J W Kugler; J Bartel; M Law; M Bateman; N E Klatt
Journal:  J Clin Oncol       Date:  1994-03       Impact factor: 44.544

View more
  7 in total

1.  Association of baseline patient characteristics with adjuvant chemotherapy toxicities in stage III colorectal cancer patients.

Authors:  Akie Watanabe; Chang Cheng Yang; Winson Y Cheung
Journal:  Med Oncol       Date:  2018-08-16       Impact factor: 3.064

2.  [Anemia in the aged].

Authors:  Gabriele Röhrig
Journal:  Z Gerontol Geriatr       Date:  2018-11-29       Impact factor: 1.281

Review 3.  Aging: Treating the Older Patient.

Authors:  Ashley Rosko; Andrew Artz
Journal:  Biol Blood Marrow Transplant       Date:  2016-11-15       Impact factor: 5.742

4.  Cancer and treatment-related symptoms are associated with mobility disability in women with ovarian cancer: A cross-sectional study.

Authors:  Grace Campbell; Teresa Hagan; Stephanie Gilbertson-White; Martin Houze; Heidi Donovan
Journal:  Gynecol Oncol       Date:  2016-09-18       Impact factor: 5.482

5.  The Association between Anemia and Parkinson's Disease: A Nested Case-Control Study Using a National Health Screening Cohort.

Authors:  Ji Hee Kim; Jae Keun Oh; Jee Hye Wee; Chan Yang Min; Dae Myoung Yoo; Hyo Geun Choi
Journal:  Brain Sci       Date:  2021-05-13

Review 6.  Anemia increases the mortality risk in patients with stroke: A meta-analysis of cohort studies.

Authors:  Zhanzhan Li; Tao Zhou; Yanyan Li; Peng Chen; Lizhang Chen
Journal:  Sci Rep       Date:  2016-05-23       Impact factor: 4.379

7.  Association Between Serum Follicle-Stimulating Hormone and Sarcopenia and Physical Disability Among Older Chinese Men: Evidence From a Cross-Sectional Study.

Authors:  Yingying Ke; Jun Xu; Xiaoyan Zhang; Qihao Guo; Yunxia Zhu
Journal:  Front Med (Lausanne)       Date:  2022-01-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.